LB Pharmaceuticals Inc Common Stock (LBRX) vs MeiraGTx Holdings plc (MGTX)
A side-by-side comparison of LB Pharmaceuticals Inc Common Stock and MeiraGTx Holdings plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LBRX
LB Pharmaceuticals Inc Common Stock
$34.12HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
MGTX
MeiraGTx Holdings plc
$10.55HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — LBRX vs MGTX
growth of $100 · dividends reinvested · last 1yLBRX +100.1% (+100.1%/yr)MGTX +42.4% (+42.4%/yr)LBRX compounded faster over this window
LBRX MGTX
LBRX vs MGTX: by the numbers
- •LBRX is the larger company ($978M vs $977M market cap).
- •MGTX is profitable (19.87% net margin) while LBRX runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | LBRX | MGTX |
|---|---|---|
| P/E ratio | N/A | 14.85 |
| Forward P/E | N/A | 35.15 |
| P/S ratio | N/A | 2.46 |
| P/B ratio | 2.94 | 4.53 |
| EV / EBITDA | N/A | 4.81 |
Profitability
| Metric | LBRX | MGTX |
|---|---|---|
| Gross margin | 0.00% | 97.19% |
| Operating margin | 0.00% | -130.20% |
| Net margin | 0.00% | 19.87% |
| ROE | -25.78% | 36.64% |
| ROIC | -28.14% | 52.81% |
Growth (annualized)
| Metric | LBRX | MGTX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 84.52% |
| Total return CAGR (5Y) | N/A | -3.10% |
Some values include inputs from SEC filing.
Frequently asked
- Is LBRX or MGTX more profitable?
- MGTX runs the higher net margin — LBRX at 0.00% versus MGTX at 19.87%.
Go deeper
Dig into the metrics
MeiraGTx P/E ratioLB Pharmaceuticals Inc Common Stock ROEMeiraGTx ROELB Pharmaceuticals Inc Common Stock operating marginMeiraGTx operating marginLB Pharmaceuticals Inc Common Stock revenue growthMeiraGTx revenue growthLB Pharmaceuticals Inc Common Stock free cash flowMeiraGTx free cash flow
LB Pharmaceuticals Inc Common Stock & MeiraGTx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.